President Trump is threatening to withhold funds from supervised drug consumption sites and potentially pursue criminal penalties against them.

HCA Healthcare and Tenet Healthcare, for-profit chains that collectively own 240 hospitals, both said their revenue and ...

Morning. Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ ...

President Trump wants to end homelessness in America. His plan? Make it easier to involuntarily treat people with serious ...

European regulators on Friday said that the Duchenne muscular dystrophy gene therapy Elevidys should not be approved ...

European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.

European regulators said that a Duchenne gene therapy should not be approved, imperiling the treatment that is also facing ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

Preauthorization is about to enter the lives of many seniors who have chosen traditional Medicare over MA, write former CMS ...

As the Trump administration reshapes biomedicine, it wants to change how scientists test drug safety: animal research.

The federal government has approved more than $4 billion in extra Medicaid funds that will be routed to hospitals, doctors, ...

As gene therapy maker Sarepta Therapeutics tangles with FDA over its Duchenne treatment, patients and their families are ...